Consequently, docetaxel preserves the GSDME function, while single-cell sequencing revealed that GSDME can induce immune cell infiltration, thereby influencing the immune microenvironment of prostate tumors and enhancing the efficacy of avelumab. This evidence concerns the gene GSDME and prostate neoplasm.